NCT06782243View on ClinicalTrials.gov

Comparison of High and Moderate Intensity Statins in Achieving the Target LDL-C Level After Acute Coronary Syndrome

NARecruitingINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

December 20, 2024

Primary Completion Date

July 30, 2025

Study Completion Date

August 25, 2025

Conditions
Acute Coronary Syndrome
Interventions
DRUG

Moderate-Intensity Statins

Participants will be administered statins based on moderate intensity. This group will receive oral tablets once daily for 3 months. The intervention includes Atorvastatin 20 mg and rosuvastatin 10 mg.

DRUG

High-Intensity Statins

Participants will be administered statins based on high intensity. This group will receive oral tablets once daily for 3 months. The intervention includes Atorvastatin 40 mg and rosuvastatin 20 mg.

Trial Locations (1)

25000

RECRUITING

MTI-KTH (Medical Teaching Institution-Khyber Teaching Hospital), Peshawar-Pakistan, Peshawar

All Listed Sponsors
collaborator

Khyber Teaching Hospital

OTHER

lead

Khyber Medical University Peshawar

OTHER